FoRx Therapeutics

Basel, Switzerland

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

$50.0M raised

Dec 2025

Series A

Biotechnology Life Science

Top Investors

Pfizer EQT Life Sciences Pfizer Venture Investments Omega Funds M Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about FoRx Therapeutics

How much funding has FoRx Therapeutics raised?

FoRx Therapeutics has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.

Who are FoRx Therapeutics's investors?

FoRx Therapeutics's investors include Pfizer, EQT Life Sciences, Pfizer Venture Investments, Omega Funds, M Ventures.

Where is FoRx Therapeutics headquartered?

FoRx Therapeutics is headquartered in Basel, Switzerland.

What does FoRx Therapeutics do?

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

What stage is FoRx Therapeutics at?

FoRx Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 18, 2025.

MLA

"FoRx Therapeutics — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/forx-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). FoRx Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/forx-therapeutics

Wikipedia (cite web)

{{cite web |title=FoRx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/forx-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 18, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K